# FDA Inspection 992601 - National Cancer Institute (NCI) - November 15, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/national-cancer-institute-nci/faed2d7a-8ad2-4eb1-9949-f6ff5b586e83/
Source feed: FDA_Inspections

> FDA Inspection 992601 for National Cancer Institute (NCI) on November 15, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 992601
- Company Name: National Cancer Institute (NCI)
- Inspection Date: 2016-11-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.globalkeysolutions.net/companies/national-cancer-institute-nci/07748909-4b54-4b85-b417-cee1bfa014cf

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c